We are committed to finding a cure for WM.

News: Health Canada has approved the use of Ibutrinib/rituximab combination

In a press release issued March 8th it was announced that Health Canada has approved the use of Ibutrinib in combination with rituximab for both first and later lines of treatment for patients of Waldenstroms Macroglobulinemia.

The release has been issued in both English and French.

https://www.newswire.ca/news-releases/imbruvica-r-ibrutinib-combination-regimen-to-treat-waldenstrom-s-macroglobulinemia-approved-through-health-canada-priority-review-857817804.html FRENCH